<div id="readability-page-1"><p>Lam Research Corporation (NASDAQ:LRCX - Get Free Report) shares rose 2.5% during trading on Monday . The company traded as high as $164.62 and last traded at $162.74. Approximately 10,152,678 shares changed hands during mid-day trading, a decline of 14% from the average daily volume of 11,786,651 shares. The stock had previously closed at $158.70.</p><h2>Analyst Ratings Changes</h2><ul><li>Applied Materials: Up 40% in 2025 With Room to Run Long-Term</li></ul><p>A number of equities research analysts recently weighed in on LRCX shares. Mizuho boosted their price objective on Lam Research from $162.00 to $170.00 and gave the stock an &#34;outperform&#34; rating in a research report on Thursday, October 23rd. TD Cowen lifted their price target on Lam Research from $145.00 to $170.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, October 23rd. Weiss Ratings  restated a &#34;buy (b)&#34; rating on shares of Lam Research in a report on Monday, December 1st. Cowen  reaffirmed a &#34;buy&#34; rating on shares of Lam Research in a research note on Thursday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Lam Research from $150.00 to $160.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, October 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have issued  a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $152.87.</p><p><b>Check Out Our Latest Research Report on Lam Research</b></p><h2>Lam Research Stock Up 2.5%</h2><ul><li>MarketBeat Week in Review – 11/10 - 11/14</li></ul><p>The firm has a market cap of $204.41 billion, a P/E ratio of 35.85, a PEG ratio of 1.63 and a beta of 1.77. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock's 50-day simple moving average is $150.02 and its 200 day simple moving average is $117.59. </p><p>Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm's revenue for the quarter was up 27.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS.  As a group, research analysts forecast that  Lam Research Corporation will post 3.71 EPS for the current fiscal year. </p><h2>Lam Research Announces Dividend</h2><ul><li>2 Reasons to Buy Into Lam’s 185% Rally, 1 Reason to Run Away</li></ul><p>The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research's dividend payout ratio  is 22.91%. </p><h2>Insider Transactions at Lam Research</h2><p>In related news, CFO Douglas R. Bettinger sold 40,080 shares of the company's stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Bethany Mayer sold 1,298 shares of the firm's stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the transaction, the director owned 1,652 shares in the company, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by insiders. </p><h2>Institutional Investors Weigh In On Lam Research</h2><p>A number of institutional investors have recently added to or reduced their stakes in the company. Sava Infond d.o.o. boosted its stake in  Lam Research by 3.1% during the 2nd quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company's stock valued at $7,325,000 after purchasing an additional 2,250 shares during the last quarter.  Horizon Bancorp Inc. IN bought a new position in shares of  Lam Research during the second quarter valued at $389,000.  Empowered Funds LLC boosted its position in shares of  Lam Research by 10.5% during the first quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company's stock valued at $13,629,000 after buying an additional 17,833 shares during the last quarter.  Genus Capital Management Inc. purchased a new stake in shares of  Lam Research during the second quarter valued at $14,476,000.  Finally, Cookson Peirce &amp; Co. Inc. bought a new stake in  Lam Research in the 1st quarter worth about $607,000. 84.61% of the stock is owned by institutional investors. </p><h2>Lam Research Company Profile</h2> (Get Free Report)<p>Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Lam Research</li><li>Canadian Penny Stocks: Can They Make You Rich? </li><li>ChargePoint's Comeback Story: Why This EV Stock Is Charging Up Again</li><li>Compound Interest and Why It Matters When Investing</li><li>5 Tech Stocks Insiders Are Selling (But Smart Investors Are Loading Up)</li><li>EV Stocks and How to Profit from Them </li><li>Why FuelCell Energy Stock Is Soaring After a Government Deal</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Lam Research Right Now?</h2><p>Before you consider Lam Research, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.</p><p>While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

LRCX

<p>Lam Research (NASDAQ:LRCX) shares rose 2.5% on Monday, trading as high as $164.62. Analysts have boosted price targets, with Mizuho and TD Cowen rating it "buy". The company reported strong earnings, with a 27.7% revenue increase year-over-year. Lam Research announced a quarterly dividend of $0.26 per share. Insider transactions include CFO Douglas Bettinger selling shares worth $6 million. Institutional investors have adjusted their stakes in the company.</p>

Lam Research (NASDAQ:LRCX) Stock Price Up 2.5% - Should You Buy?